Celladon
Biotechnology company developing molecular therapies for the treatment of heart failure.
Employees
Enterprise value
$87—131m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
N/A | Merger | ||
| Total Funding | 000k | ||
Venrock(exited)
Kleiner Perkins(exited)
Enterprise Partners(exited)
Domain Associates(exited)
Lundbeckfonden Ventures(exited)
Lundbeckfonden(exited)
University of Minnesota(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads